Safety and Activity of SNX-5422 Plus Ibrutinib in CLL
Clinical trial NCT02914327 · WITHDRAWN
Trial details
- NCT number
- NCT02914327
- Sponsor
- Esanex Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-02
- Primary completion
- 2018-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.